IP Library Granted Patent US 8,759,092
Granted Patent B2
US 8,759,092 · App. 12/869,526 · Granted Jun 24, 2014

Preparation of vaccines using photosensitizer and light

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,759,092
App. No.
12/869,526
Granted
Jun 24, 2014
Kind
B2
Abstract

Methods are provided for treating a vaccine containing infectious particles which may be viral, bacterial, and/or cellular in nature. Preferred methods include the steps of adding an effective, non-toxic amount of an endogenous photosensitizer to the fluid and exposing the fluid to photoradiation sufficient to inactivate the infectious particles but not enough to damage the antigenic characteristics of the infectious particles.

Claims (11)

1. A method of making a composition comprising inactivated tumor cells, wherein the composition comprising the inactivated tumor cells is administered to a patient, the method comprising:

removing a tumor from the patient;

purifying at least some tumor cells from the tumor;

containing the tumor cells in a photopermeable container for radiation;

adding an endogenous photosensitizer to the photopermeable container, wherein the endogenous photosensitizer comprises 7,8-dimethyl-10-ribityl isoalloxazine, and wherein the endogenous photosensitizer is at a concentration of at least about 10 μM;

inactivating the tumor cells by exposing the tumor cells to the endogenous photosensitizer and light at a sufficient wavelength to prevent replication of the tumor cells but not substantially destroy the antigenic determinants of the tumor cells, wherein the exposing comprises:

irradiating the tumor cells and the endogenous photosensitizer in the photopermeable container at a range of between about 1 to about 120 J/cm 2 for a period of between about 6 to about 36 minutes;

suspending the inactivated tumor cells in a suspension solution to make the composition comprising the inactivated tumor cells, wherein the suspension solution comprises one or more from the group consisting of: saline and water; and

administering the composition comprising the inactivated tumor cells to the patient subcutaneously, intramuscularly, intraperitoneally, orally, or nasally.

2. The method of claim 1 , wherein the suspension solution comprises one or more from the group consisting of: an antibiotic and a preservative.

3. The method of claim 1 , wherein the suspension solution comprises an adjuvant.

Assignments (2)
CHANGE OF NAME Recorded Feb 16, 2012
From: CARIDIANBCT BIOTECHNOLOGIES, LLC.
To: TERUMO BCT BIOTECHNOLOGIES, LLC
Reel/Frame 027715/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2010
From: GOODRICH, RAYMOND P.
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 024895/0265 →